---
title: "Atorvastatin - Hyperlipoproteinemia Type Iii"
sidebar: mydoc_sidebar
permalink: db01076-mesh-d006952-1.html
toc: false 
---


Path ID: `DB01076_MESH_D006952_1`
{% include image.html url="images/db01076-mesh-d006952-1.png" file="db01076-mesh-d006952-1.png" alt="db01076-mesh-d006952-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D000069059">MESH:D000069059 </a> | atorvastatin | Drug |
| <a href="https://identifiers.org/UniProt:P04035">UniProt:P04035 </a> | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Protein |
| <a href="https://identifiers.org/UniProt:P06858">UniProt:P06858 </a> | Lipoprotein lipase | Protein |
| <a href="https://identifiers.org/GO:0006695">GO:0006695 </a> | cholesterol biosynthetic process | BiologicalProcess |
| <a href="https://identifiers.org/GO:0019433">GO:0019433 </a> | triglyceride catabolic process | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D002784">MESH:D002784 </a> | Cholesterol | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D014280">MESH:D014280 </a> | Triglycerides | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D006952">MESH:D006952 </a> | Hyperlipoproteinemia Type III | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Atorvastatin | DECREASES ACTIVITY OF | 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase |
| Atorvastatin | INCREASES ACTIVITY OF | Lipoprotein Lipase |
| 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase | POSITIVELY REGULATES | Cholesterol Biosynthetic Process |
| Lipoprotein Lipase | POSITIVELY REGULATES | Triglyceride Catabolic Process |
| Cholesterol Biosynthetic Process | INCREASES ABUNDANCE OF | Cholesterol |
| Triglyceride Catabolic Process | DECREASES ABUNDANCE OF | Triglycerides |
| Cholesterol | POSITIVELY CORRELATED WITH | Hyperlipoproteinemia Type Iii |
| Triglycerides | POSITIVELY CORRELATED WITH | Hyperlipoproteinemia Type Iii |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01076#mechanism-of-action](https://go.drugbank.com/drugs/DB01076#mechanism-of-action)
  - [https://www.uniprot.org/uniprot/P04035#function](https://www.uniprot.org/uniprot/P04035#function)
  - [https://www.uniprot.org/uniprot/P06858#function](https://www.uniprot.org/uniprot/P06858#function)
  - [https://pubmed.ncbi.nlm.nih.gov/15262189/](https://pubmed.ncbi.nlm.nih.gov/15262189/)
  - [https://en.wikipedia.org/wiki/Familial_dysbetalipoproteinemia](https://en.wikipedia.org/wiki/Familial_dysbetalipoproteinemia)
